Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Central Nervous System Neoplasms; Glioblastoma; Nervous System Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
CONTENTS